Top 5 Blue Chip Stocks To Invest In Right Now

One of the most difficult aspects of trading is timing the market. Odds are if you have been in the market over the past nine years, most likely you made some money. This bull market began in March of 2009, and 24/7 Wall St. is looking back to see how some major blue chip stocks compared to the broad markets over this time.

Back on March 6, 2009, the S&P 500 bottomed out at 666.79, and from there began perhaps the biggest bull market of the modern era. At the most recent close, the S&P 500 was at 2,677.67, more than quadrupling its bottom nearly nine years ago.

So how does Goldman Sachs Group Inc. (NYSE: GS) compare to the markets over the past nine years?

On an adjusted close basis, Goldman Sachs ended March 6, 2009, at $72.89 a share, or $81.72 on an unadjusted basis. Goldman Sachs most recently closed at $256.78 on an adjusted basis.

Checking the numbers, its fairly obvious that Goldman Sachss growth over this period has lagged the broad markets, with shares gaining only 250%. If you had invested $1,000 in Goldman Sachs back then, you would have just $3,522.84 as of Thursdays close.

Top 5 Blue Chip Stocks To Invest In Right Now: Itron Inc.(ITRI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Itron (NASDAQ:ITRI) major shareholder Scopia Capital Management Lp purchased 114,129 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was purchased at an average price of $59.34 per share, for a total transaction of $6,772,414.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

  • [By Stephan Byrd]

    Itron (NASDAQ: ITRI) and Data I/O (NASDAQ:DAIO) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Agilent Technologies, Inc. (NYSE: A) is estimated to post quarterly earnings at $0.64 per share on revenue of $1.21 billion.
    Vipshop Holdings Limited (NYSE: VIPS) is expected to post quarterly earnings at $0.18 per share on revenue of $3.10 billion.
    Rexnord Corporation (NYSE: RXN) is projected to post quarterly earnings at $0.39 per share on revenue of $551.94 million.
    Invitation Homes Inc. (NYSE: INVH) is estimated to post quarterly earnings at $0.03 per share on revenue of $423.13 million.
    Switch, Inc. (NYSE: SWCH) is expected to post quarterly earnings at $0.05 per share on revenue of $99.83 million.
    Itron, Inc. (NASDAQ: ITRI) is projected to post quarterly earnings at $0.13 per share on revenue of $579.85 million.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) is expected to post quarterly earnings at $0.44 per share on revenue of $119.06 million.
    Amyris, Inc. (NASDAQ: AMRS) is estimated to post quarterly earnings at $0.07 per share on revenue of $68.14 million.
    Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) is projected to post quarterly loss at $0.38 per share on revenue of $1.87 million.
    VOXX International Corporation (NASDAQ: VOXX) is expected to post quarterly earnings at $0.05 per share on revenue of $130.00 million.
    Phoenix New Media Limited (NYSE: FENG) is estimated to post quarterly loss at $0.12 per share on revenue of $45.38 million.
    Restoration Robotics, Inc. (NASDAQ: HAIR) is projected to post quarterly loss at $0.17 per share on revenue of $5.93 million.
    YogaWorks, Inc. (NASDAQ: YOGA) is estimated to post quarterly loss at $0.22 per share on revenue of

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Itron (ITRI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Data I/O (NASDAQ: DAIO) and Itron (NASDAQ:ITRI) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Itron (ITRI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Invest In Right Now: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Shane Hupp]

    FinnCap cut shares of Avingtrans (LON:AVG) to a corporate rating in a research report report published on Monday.

    Shares of LON:AVG opened at GBX 223 ($2.97) on Monday. Avingtrans has a one year low of GBX 174.11 ($2.32) and a one year high of GBX 260 ($3.46).

Top 5 Blue Chip Stocks To Invest In Right Now: ICON plc(ICLR)

Advisors’ Opinion:

  • [By Lee Jackson]

    Icon
    Based in Ireland, this top company is offering investors a nice entry point. Icon PLC (NASDAQ: ICLR) is a global contract research organization (CRO) providing clinical development services to pharmaceutical, biotechnology and medical device industries.

  • [By Logan Wallace]

    Senomyx (NASDAQ: SNMX) and ICON (NASDAQ:ICLR) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

  • [By Joseph Griffin]

    Icon Plc (NASDAQ:ICLR) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $127.20.

  • [By Stephan Byrd]

    Financial Gravity Wealth Inc. acquired a new position in shares of Icon Plc (NASDAQ:ICLR) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,524 shares of the medical research company’s stock, valued at approximately $179,000.

Top 5 Blue Chip Stocks To Invest In Right Now: Electronics for Imaging Inc.(EFII)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Electronics For Imaging (EFII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Natixis Advisors L.P. lifted its stake in Electronics For Imaging, Inc. (NASDAQ:EFII) by 20.1% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,439 shares of the technology company’s stock after buying an additional 3,582 shares during the quarter. Natixis Advisors L.P.’s holdings in Electronics For Imaging were worth $586,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Joseph Griffin]

    Metropolitan Life Insurance Co. NY lessened its holdings in shares of Electronics For Imaging, Inc. (NASDAQ:EFII) by 53.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 14,882 shares of the technology company’s stock after selling 17,018 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Electronics For Imaging were worth $439,000 at the end of the most recent reporting period.

Top 5 Blue Chip Stocks To Invest In Right Now: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Cellectis SA (NASDAQ:CLLS) have earned an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.00.

Leave a Reply

Your email address will not be published. Required fields are marked *